This topic contains a solution. Click here to go to the answer

Author Question: The most likely cause of immediate hemolytic transfusion reaction is from antibodies of which ... (Read 74 times)

skymedlock

  • Hero Member
  • *****
  • Posts: 561
The most likely cause of immediate hemolytic transfusion reaction is from antibodies of which system?
 
  a. Kidd
  b. Rh
  c. ABO
  d. I

Question 2

Which of the following is consistent with a diagnosis of CAD?
 
  a. MCHC 44 g/dL
  b. DAT positive with polyspecific AHG and anti-IgG
  c. Spherocytes on the peripheral blood smear
  d. MCV 104 fL



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

sierramartinez

  • Sr. Member
  • ****
  • Posts: 313
Answer to Question 1

Correct Answer: C

Answer to Question 2

Correct Answer: D
C is also a correct answer




skymedlock

  • Member
  • Posts: 561
Reply 2 on: Jun 25, 2018
Gracias!


parshano

  • Member
  • Posts: 333
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Patients who have been on total parenteral nutrition for more than a few days may need to have foods gradually reintroduced to give the digestive tract time to start working again.

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

Thyroid conditions cause a higher risk of fibromyalgia and chronic fatigue syndrome.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library